$ACMR

Acm Research CFO Mark McKechnie sells $4.2m in stock

ACM Research CFO Mark McKechnie sold $4.26M in shares and acquired $935,828 worth via options. Shares sold at $76.34-$77.89, currently at $79.41. ACMR reported Q2 earnings of $0.61 per share on $292.9M revenue, beating estimates. The company raised its full-year revenue outlook. Analysts note high volatility and potential overvaluation.

Original reporting
Published Aug 22, 2026, 2:20 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 3:13 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ACMR
Bearish
medium confidence
Mentioned
$ACMR
Relevance
5/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$ACMRBearishLow
01

Why it matters

The insider transaction adds a fresh data point for short‑term traders, while earnings momentum supports a bullish view.

02

Market read

Insider sale is the primary new event; earnings already priced in.

03

What to watch

Recent strong Q2 earnings and raised revenue outlook could mitigate negative sentiment from the sale.

Relevance 5/10Novelty 7/10Timing: today

Background

ACMR reported Q2 2026 earnings beat and raised its full‑year revenue outlook.

Company-level read

Ticker impact

$ACMRBearishMedium confidence
Context

CFO Mark McKechnie sold $4.26M of ACMR shares under a Rule 10b5‑1 plan on Aug 20, 2026.

Expected impact

Slight downward bias in intraday trading; watch for volume spikes.

Evidence & confidence

Insider sale signals possible concerns, but the CFO also exercised options, indicating confidence.

Market effects

Minimal impact on semiconductor equipment sector beyond ACMR.

US market only; no broader regional effect.

Low; limited to investors tracking insider activity.

Counterpoint

The CFO's option exercise may offset the sale, suggesting confidence in long‑term upside.

Key entities

  • Mark McKechnie

    Chief Financial Officer of ACM Research

Related articles

$ACMRMed

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

$ACMRMedAI 9/10

ACM Research (ACMR) Q2 2026 Earnings Call Transcript

ACM Research (ACMR) reported Q2 2026 revenue of $292.9M, up 36% year over year, with non-GAAP diluted EPS of $0.61. Non-GAAP gross margin was 46.0%. The company raised 2026 revenue guidance to $1.125B-$1.175B and said first-half orders rose 105%. Net cash was $1.0B.

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.